Specifically, delta-like canonical Notch ligand 3 (DLL3), BCL2 apoptosis regulator (BCL2), and lysine demethylase 1 A (LSD1) were considered promising targets in SCLC-A tumors. The gene discussed is DLL3; the disease is small cell lung carcinoma.